STAT4h
Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Mena FN1d
75+ Key Companies Charting New Frontiers In Multiple Sclerosis Therapeutic Space Delveinsight
Continuous research has led to new drug developments, particularly disease-modifying ... FibroBiologics, Kyverna Therapeutics, GlaxoSmithKline, PolTREG, Cyxone, Biohaven Pharmaceuticals, HuniLife ...
NDTV8d
Mira Kapoor Enjoyed Vegan Sushi On Her Foodie Trail In New York - See Pic
One of her most recent updates is from New York, where she recently went with Shahid Kapoor. She posted a picture from a restaurant there and simply captioned it, "Vegan Trail". In the photo, two ...
BioPharma Dive14d
GSK vaccine sales sink on lower demand for RSV, shingles shots
The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...
Business Insider15d
GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today ...
Bloomberg L.P.16d
GSK Inks Lupus Deal With Chinese Biotech for Up to $850 Million
GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.
Reuters16d
India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand
Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...
Business Insider16d
GSK to acquire CMG1A46 from Chimagen Biosciences
GSK (GSK) plc and Chimagen Biosciences, a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager, from ...
Pharmabiz20d
New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease
GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due to certain underlying medical ...
Deadline.com20d
Sony Adds Untitled ‘Spider-Man’ With Tom Holland To Summer 2026 Calendar; Destin Daniel Cretton Directing
Euan Cherry / Getty Images / Sony Pictures Releasing / Marvel Entertainment / Courtesy Everett Collection The new untitled Spider-Man movie has been added to the release calendar for July 24 ...
The Pharma Letter20d
New data for GSK’s Arexvy RSV vaccine
US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...